Speaker Profile

Ph.D., Founder & CEO, iNanoBio Inc

Dr. Bharath Takulapalli is Founder CEO of iNanoBio, a startup developing advanced technologies at the interface of nanotechnology, biology and machine learning (ML). Bharath believes that, as a scientific community, we can preempt 90% of all diseases. Disease preemption implies detection in predisease stages, followed by early intervention and cure, before disease onset. To contribute, iNanoBio is developing two product platforms to extract 100x more information from systems biology (genotype and phenotype) than currently possible. First is a novel semiconductor nanopore transistor device to sequence the DNA 1000X faster than state of art, and 90% less expensive. The second is a firstofkind proteomic technology termed SPOC (Sensorintegrated Proteome on Chip) to study protein kinetic interactions at scale. We successfully developed functional prototypes of proteinbiosensor chips and SPOC Proteomics Inc is set for researchuse commercial launch in 2024 and CLIA tests in 202526. iNanoBio is based out of Menlo Park, California and Scottsdale, Arizona.

Novel SPOC Proteomic biosensor Technology to Study Proteins at Scale

Clinical & Research Tools Showcase:
iNanoBio Inc

iNanoBio is developing advanced technologies at the interface of nanotechnology, biology and machine learning (ML). iNanoBio's two novel product platforms aim to extract 100x information from systems biology than possible today (i) FENT for 1000x faster DNA sequencing (ii) SPOC for studying proteins at scale.

 Session Abstract – PMWC 2024 Silicon Valley

Showcase Track S2 - January 24 2.00 P.M.-2.45 P.M.,Showcase Track S2 - January 25 2.15 P.M.-3.00 P.M.,Showcase Track S2 - January 26 11.30 A.M.-3.45 P.M.

The PMWC 2023 Clinical & Research Tools Showcase will provide a 15-minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.


Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by SEP. 28TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required